GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

The pharmaceutical intermediates market faces several challenges. Regulations are becoming more stringent globally which increases compliance costs. Additionally, price controls imposed by various countries impact profit margins. Developing innovative intermediates also requires huge investments in R&D. Securing reliable suppliers for key starting materials and facing intense competition from generics manufacturers further add to the challenges in this industry.

Market Opportunities – Rise in non-communicable diseases:

The pharmaceutical intermediates market also presents several opportunities for growth. As lifespans increase and non-communicable diseases rise, the demand for drugs will continue expanding worldwide. Outsourcing of intermediate production provides opportunity to capture a share of the global supplies. Emerging markets like India and China with their large populations offer vast potential for sales. Developing intermediates for niche therapy areas and orphan drugs can help gain higher margins.